Management of CKD with Active Convulsion

Medication Management and Metabolic Considerations

• CKD patients are particularly susceptible to electrolyte abnormalities (hyperkalemia, hypocalcemia, hypomagnesemia) and uremic encephalopathy that can cause seizures, according to the Kidney International guidelines 1
• Review all medications for potential seizure-inducing agents, as CKD patients are more susceptible to drug toxicity due to impaired clearance, as noted in Kidney International 1
• Immediately review all current medications for nephrotoxicity and dose appropriateness based on eGFR, as recommended by Kidney International 1
• If maintenance anticonvulsant therapy is needed, calculate actual creatinine clearance using Cockcroft-Gault equation and adjust doses accordingly, as suggested by Kidney International and Praxis Medical Insights 1, 2
• Refer to nephrology if eGFR <30 mL/min/1.73 m², persistent electrolyte abnormalities, or uncertain cause of CKD, according to Kidney International 3
• Do not rely on serum creatinine alone for drug dosing in CKD—always calculate creatinine clearance, as recommended by Kidney International and Praxis Medical Insights 1, 2